Insmed Inc INSM

NAS: INSM | ISIN: US4576693075 1/12/2023

26,52 USD (+6,00%)

(+6,00%) 1/12/2023

Grafiek Insmed Inc

Grafiek Insmed Inc

1 dag1d 6,00%
1 week1w 10,78%
1 maand1m 6,04%
3 maanden3m 0,57%
6 maanden6m 35,72%
1 jaar1j 30,19%
5 jaar5j 41,82%

Insmed Inc in het nieuws

Toon enkel gratis nieuws

8 september 2023 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

6 september 2023 · Insmed To Present at the Morgan Stanley 21st Annual Global Healthcare Conference · Persbericht

5 september 2023 · Insmed Announces Positive Topline Results From Phase 3 Arise Study Of Arikayce® (Amikacin Liposome Inhalation Suspension) In Patients With Ntm Lung Disease Caused By Mac · Persbericht

4 augustus 2023 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

3 augustus 2023 · Insmed Reports Second-Quarter 2023 Financial Results and Provides Business Update · Persbericht

20 juli 2023 · Insmed to Host Second-Quarter 2023 Financial Results Conference Call on Thursday, August 3, 2023 · Persbericht

7 juli 2023 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

7 juni 2023 · Insmed To Present at the Goldman Sachs 44th Annual Global Healthcare Conference · Persbericht

6 juni 2023 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

22 mei 2023 · Insmed Presents Range of New Study Findings at American Thoracic Society 2023 International Conference · Persbericht

Profiel Insmed Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.insmed.com

Hoofdzetel: Bridgewater, New Jersey Verenigde Staten

CEO: William Lewis

Werknemers: 778

Aandelen Insmed Inc

Beurswaarde: 3,58 miljard USD

Effecten: 143,06 miljoen

Winst per aandeel (12 maand): PLUS

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe